baber/WOPTO huggingface dataset:
Patent NZ-581014-A (NZ)
Title: Flip-lid dispensing closure and package
Inventor: ROBINSON PHILIP J
IPC: B65D47/08
Filed: 2008-05-05
Abstract: A moulded one piece plastic closure comprises a base 30 with a lid 28 where the lid 28 is integrally connected to the base 30 by a hinge 32. The hinge 32 is radially inwardly displaced from an outer periphery of the base 30. When the lid 28 is closed the central portion of the hinge 32 has a convex outer surface when viewed in side elevation, with the convex outer surface blending with a smooth curvature into outer surfaces of the lid 28 and the base 30. The hinge 32 has laterally spaced end portions on opposite sides of its central portion 52. The end portions 54, 56 have concave outer surfaces when the lid 28 is closed. The base 30 has a circular periphery. The end portions 54, 56 of the hinge 32 are angularly spaced from each other. The lid 28 is integrally connected to the base 30 as moulded by at least one frangible bridge 46 spaced away from the hinge 32.
Patent NZ-582760-A (NZ)
Title: Substituted imidazoheterocycles
Inventor: BECKETT R
IPC: C07H17/02
Filed: 2008-06-20
Abstract: Substituted imidazoheterocyclic compounds having the structure of formula (I) are disclosed, wherein the variables are as defined in the specification. Also disclosed are pharmaceutically acceptable salts, acid salts, hydrates, solvates and stereoisomers of the compounds of formula I. The compounds are useful as modulators of cannabinoid receptors and for the prophylaxis and treatment of cannabinoid receptor- associated diseases and conditions, such as pain, inflammation, immunomodulation, pruritis, obesity and abnormal osteoclastogenesis, wherein the pain may be: neuropathic pain, somatic pain, visceral pain, cutaneous pain, ocular pain, otic pain, diabetic pain, inflammatory pain, pain associated with inflammatory bowel disease or irritable bowel syndrome, break-through cancer pain, metastatic cancer pain, hyperalgesia, virally-induced pain, or chemotherapy-induced pain..
Patent NZ-585073-A (NZ)
Title: Aryloxy amine compounds and their use as sodium channel modulators
Inventor: JARROTT BEVYN
IPC: C07D213/68
Filed: 2008-10-31
Abstract: Disclosed are aryloxy amine compounds of formula (I), salts and solvates thereof, and methods for their preparation. A is cyclopentadienyl, phenyl, heteroaryl group, or napthyl; B is a substituted phenyl ring L1 and L2 are alkylene, alkenylene, or alkynylene chains A specific example of a compound of formula (I) is 4-{ ([2-(2,6-dimethylphenoxy)-1-methylethyl]amino)methyl} -(3-methylphenol). Compounds of formula (I) are useful for treating conditions where excessive or undesirable sodium channel activity is implicated. Such conditions include neuroinflammatory disease, neuropathic pain, spinal cord injury, axonal loss, degeneration or damage, a demyelinating disease or central or peripheral neuropathy.
Patent NZ-588895-A (NZ)
Title: Recombinant human CC10 (rhCC10 aka uteroglobin) and compositions thereof for use in the treatment of nasal rhinitis
Inventor: PILON APRILE L
IPC: A61K38/17
Filed: 2009-05-12
Abstract: Disclosed is a use of recombinant human CC10 (rhCC10), also known as recombinant human uteroglobin, for use as a therapeutic in the treatment of nasal rhinitis, nasal sinusitis, chronic rhinosinusitis, and nasal polyposis. More particularly, the invention provides methods, including broadly the critical dosage ranges of rhCC10 and intranasal route of administration, which may be administered to safely and effectively treat the aforementioned conditions. The invention further provides a composition useful in administering rhCC10 to humans.
Patent NZ-592744-A (NZ)
Title: Windowed statistical analysis for anomaly detection in geophysical datasets
Inventor: KUMARAN KRISHNAN
IPC: G01V1/00
Filed: 2009-09-30
Abstract: A method for identifying geologic features in one or more 2D or 3D discretized sets of geophysical data or data attribute (each such data set referred to as an "original data volume") representing a subsurface region, comprises (a) selecting a data window shape and size; (b) for each original data volume, moving the window to a plurality of overlapping or non-overlapping positions in the original data volume such that each data voxel is included in at least one window, and forming for each window a data window vector I whose components consist of voxel values from within that window; (c) using the data window vectors to perform a statistical analysis and compute a distribution for data values, the statistical analysis being performed jointly in the case of a plurality of original data volumes; (d) using the data value distribution to identify outliers or anomalies in the data; and (e) using the outliers or anomalies to predict geologic features of the subsurface region. Use of this method in predicting petroleum potential of a subsurface region is also disclosed.
Patent NZ-593419-A (NZ)
Title: Lockable rotary electrical switch with at least one collar aperture located below a horizontal centre line
Inventor: VITALONE PASQUALE
IPC: H01H9/28
Filed: 2009-12-21
Abstract: 593419 Disclosed is an electrical switch assembly (1). The assembly (1) includes a rotary switch (8) having a circular face which is rotatably nested in a collar (50) extending from a base (2). At least one collar aperture (20, 30) pass through the collar (50) so that an outer end of the at least one collar aperture (20, 30) is located in an outer surface of the collar (50) and an inner end of the at least one collar aperture (20, 30) is located in an inner surface of the collar (50). At least the outer end of each of the at least one collar aperture (20, 30) is located at a level which is below a level of a horizontal centre line (a).
Patent NZ-594793-A (NZ)
Title: Method and system for accounting for usage of a wireless access network
Inventor: RALEIGH GREGORY G
IPC: H04L12/14
Filed: 2010-01-19
Abstract: A system and a method of accounting for usage of a wireless access network are disclosed. The system comprises one or more user interfaces configured to accept service administrator inputs defining a bill-by-account service policy applicable to a device group and one or more networks elements. The device group includes one or more end-user devices communicatively coupled or capable of being coupled to the system over a wireless access network and each end-user device in the device group is identified by a unique credential differentiating that end-user device from all other end-user devices in the device group. The bill-by-account service policy is to be applied when any end-user device in the device group communicates or attempts to communicate over the wireless access network and the bill-by-account service policy comprises a classification policy to assist in identifying one or more bill-by-account service activities with the one or more bill-by-account service activities being a subset of all service activities available over the wireless access network, and a charging policy to assist in accounting for usage of the wireless access network associated with the one or more bill-by-account service activities. The one or more networks elements are configured to: identify attempted or successful wireless access network traffic associated with a particular end-user device in the device group with the particular end-user device identified by a particular credential, using at least a portion of the classification policy, identify a particular service activity within the attempted or successful wireless access network traffic associated with the particular end-user device with the particular service activity being one of the one or more bill-by account service activities, obtain a charging record comprising the particular credential and a usage measure providing an indication of a wireless access network usage associated with the particular service activity by the particular end user device, and based on the charging policy, allocate at least a portion of the usage measure to an account associated with an entity responsible for at least a portion of the wireless access network usage associated with the particular service activity by the particular end-user device.
Patent NZ-600079-A (NZ)
Title: A monoclonal antibody to cd44 for use in the treatment of head and neck squamous cell carcinoma
Inventor: DA CRUZ LUIS A
IPC: A61K39/00
Filed: 2011-02-02
Abstract: Patent No. 600079 Disclosed is the use of a monoclonal anti-CD44 antibody or antigen biding fragment thereof, for the manufacture of a medicament for the treatment of a head and neck squamous cell carcinoma (HNSCC) in a mammal, wherein said HNSCC is characterized by the expression of CD44.
Patent NZ-613871-A (NZ)
Title: Refreshing beverage
Inventor: COY JOHANNES
IPC: A23L33/00
Filed: 2011-12-20
Abstract: Disclosed a sweet-tasting refreshing beverage that is free from phosphoric acid, is low in minerals and is low in sugar, characterised in that, it has a content of gluconic acid that is at least 0.3 wt/vol %, in that any content of minerals is less than 250 mg/litre, in that it has a content of sugars of at most 2.5 wt/vol %, in that the content of sugars comprises a fraction of galactose that is at least 10 weight-weight % based on the content of sugars, in that it additionally comprises a content of isomaltulose and/or tagatose and/or trehalose and/or ribose, and in that the beverage has a glycemic index of at most 35.
Patent NZ-618192-A (NZ)
Title: A device and method of taking samples from medical equipment for the purpose of microbiological testing
Inventor: CONNOR GUY
IPC: G01N1/14
Filed: 2012-01-11
Abstract: 618192 Disclosed is a device and method for use in taking a sample from an item of medical equipment for the purpose of microbiological testing to ensure that the medical equipment remains to a sterile condition. The device includes attachment means for attaching about a region of the item of medical equipment in an air-tight manner; and collection means for collecting fluid which emanates from the item of medical equipment. The attachment means includes a resilient portion in the form of a membrane which includes an aperture, the membrane forms an air-tight seal by way of being an interference fit about the region of the item of medical equipment. A suction means in the form of a cylinder and plunger arrangement of a sterile syringe sucks air from the collection means, to thereby draw fluid from the item of medical equipment.
Patent NZ-618267-A (NZ)
Title: Roller blind bottom bar
IPC: E06B9/42
Filed: 2013-11-27
Abstract: 618267 Disclosed are a roller blind including a roller tube (34) mounted for rotation and a kit of parts for assembling a roller blind. Edges of a blind contact end portions of current roller blind bottom bars during deployment or retraction of the blind resulting in fraying of the side edges of the sheet. The roller blind further includes a fixed element (32) and a sheet element (16). The fixed element (32) is located adjacent to the roller tube (34). The sheet element (16) is secured to one end of the roller tube (34) and at the opposite end to the fixed element (32) such that the sheet element defines a return portion located between the two ends. A roller blind bottom bar (4) is located within the return portion includes a tubular body and an end cap (2) at each end. The end caps (2) include proximal (6) and distal (8) portions. The proximal portion (6) is located adjacent to the tubular body and the distal portion (8) is spaced from the tubular body. An outwardly flared portion (10) is located between the proximal (6) and distal (8) portions such that the end cap (4) flares outwards from the proximal portion (6) to the distal portion (8). The end cap further includes one or more outwardly extending deformable ribs (12).
Patent NZ-620691-A (NZ)
Title: Method for forming a tubular container for food products and resulting container
Inventor: NEVOT BANUS JORDI
IPC: B65D77/04
Filed: 2012-07-06
Abstract: A method for forming a tubular container for food products and the resulting container. The method comprises the following steps performed on a flexible sheet. Folding or rolling a portion of the flexible sheet in order to form a first tubular body. Sealing one of the bases of the first tubular body. Folding or rolling the rest of the flexible sheet, which does not form part of the first tubular body, concentrically around the first tubular body, forming a second tubular body outside the first tubular body. Joining part of the final longitudinal end of the inner surface of the second tubular body to part of the outer surface of the first tubular body, forming two independent cavities. The cavities are namely a first cavity (4) inside the first tubular body and a second cavity (5) inside the second tubular body and outside the first tubular body. The first cavity may contain a first food product therein, and the second cavity may contain a second food product therein. The food products may be in a solid, powdered, or liquid state and may be placed indistinctly in one cavity or the other.
Patent NZ-621873-A (NZ)
Title: Biaxially stretched polyester film and method for producing same
Inventor: OKUZU TAKAYOSHI
IPC: C08L67/02
Filed: 2012-09-03
Abstract: A biaxially stretched polyester film which contains a modified polybutylene terephthalate (modified PBT) and a polyethylene terephthalate (PET). The biaxially stretched polyester film is characterized in that: the mass ratio of the modified PBT to the PET, namely (modified PBT/PET) is from 20/80 to 5/95; the modified PBT is a PBT that contains 5-20% by mass of a polytetramethylene glycol unit that has a molecular weight of 600-4,000; the amount of tetrahydrofuran (THF) generated by heating the biaxially stretched film at 180°C for 30 minutes in a helium gas atmosphere is 50 μg/g or less; and the biaxially stretched polyester film has tear linearity in the longitudinal direction.
Patent NZ-626314-A (NZ)
Title: 1,6-diazabicyclo[3,2,1]octan-7-one derivatives and their use in the treatment of bacterial infections
Inventor: PATIL VIJAYKUMAR JAGDISHWAR
IPC: C07D471/18
Filed: 2013-04-19
Abstract: Disclosed are 7-oxo-6-(sulphooxy)-1,6-diazabicyclo[3.2.1]octane-2-carboxamide derivatives and prodrugs of Formula (I) or a stereoisomer or a pharmaceutically acceptable salt thereof; wherein: R1 is: SO3M, SO2NH2, PO3M, CH2COOM, CF2COOM, CHFCOOM, or CF3; M is hydrogen or a cation; R2 is: hydrogen, (CH2)n-R3, or COOR3; R3 is: hydrogen, optionally substituted alkyl, CN, NR6R7, CONR6R7, NHCONR6R7, optionally substituted aryl, optionally substituted heterocyclyl, optionally substituted heteroaryl, optionally substituted cycloalkyl, or OR8; and wherein the remaining substituents are as defined herein, and wherein said alkyl is a branched or unbranched saturated acyclic hydrocarbon radical with 1 to 6 carbon atoms; said cycloalkyl is a three to seven member saturated or unsaturated cyclic hydrocarbon radical; said heterocyclyl is a four to seven member cycloalkyl group containing one or more heteroatoms selected from nitrogen, oxygen or sulfur; said aryl is a monocyclic or polycyclic aromatic hydrocarbon containing six to fourteen ring atoms; and said heteroaryl is a monocyclic or polycyclic aromatic hydrocarbon wherein one or more carbon atoms have been replaced with heteroatoms selected from nitrogen, oxygen, or sulfur. Representative compounds include (2S,5R)-N-{ [(2S,4R)-4-trifluoroacetylamino-pyrrolidin-2-yl]methyloxy} -7-oxo-6-(sulfooxy)-1,6-diazabicyclo[3.2.1]octane-2-carboxamide, (2S,5R)-N-{ [(2S)-1-carbamimidoyl-pyrrolidin-2-yl]methyloxy} -7-oxo-6-(sulfooxy)-1,6-diazabicyclo[3.2.1]octane-2-carboxamide, (2S,5R)-7-oxo-N-{ [(2S)-5-oxopyrrolidin-2-yl]methyloxy} -6-(sulfooxy)-1,6-diazabicyclo [3.2.1]octane-2-carboxamide, (2S,5R)-7-oxo-N-{ [(4S)-2-(2-hydroxyphenyl)-4,5-dihydro-1,3-oxazol-4-yl]methyloxy} -6-(sulfooxy)-1,6-diazabicyclo[3.2.1]octane-2-carboxamide, (2S,5R)-7-oxo-N-[(2S)-pyrrolidin-2-ylmethyloxy]-6-(sulfooxy)-1,6-diazabicyclo[3.2.1]octane-2-carboxamide, (2S,5R)-N-{ [(2S,4R)-4-hydroxyl-pyrrolidin-2-yl]methyloxy} -7-oxo-6-(sulfooxy)-1,6-diazabicyclo[3.2.1]octane-2-carboxamide, (2S,5R)-N-[(2R)-azetidin-2-ylmethyloxy]-7-oxo-6-(sulfooxy)-1,6-diazabicyclo[3.2.1]octane-2-carboxamide, and (2S,5R)-N-hydroxy-7-oxo-6-(sulfooxy)-1,6-diazabicyclo[3.2.1]octane-2-carboxamide sodium salt. Also disclosed is a pharmaceutical composition comprising a compound as defined above, and optionally further comprising at least one antibacterial agent and/or beta-lactamase inhibitor (such as sulbactam, tazobactam and/or clavulanic acid), for the prevention or treatment of a bacterial infection in a subject, including for the treatment of infection caused by bacteria producing one or more beta-lactamase enzymes.
Patent NZ-628863-A (NZ)
Title: A process for cleaning a transport belt for manufacturing a paper web
Inventor: HUNTER MARK S
IPC: D21F1/32
Filed: 2013-03-21
Abstract: A method of effectively cleaning a moving papermaking fabric comprising subjecting a fabric to be cleaned to an initial cleaning stage, wherein the initial cleaning stage includes the application of a cleaning medium comprising both steam and superheated water at a temperature of greater than 100°C from an initial cleaning assembly that spans the entire width of the fabric to be cleaned; subjecting the fabric to be cleaned to a second cleaning stage, wherein the second cleaning stage includes the application of a cleaning medium comprising both steam and superheated water from a second cleaning assembly that spans the entire width of the fabric to be cleaned.
Patent NZ-630243-A (NZ)
Title: Brushless dc motor
Inventor: MOSTOVOY ALEXANDER
IPC: H02K21/12
Filed: 2013-03-19
Abstract: Disclosed is a brushless DC motor capable of generating a substantially constant torque regardless of an angular velocity of its rotor. The brushless DC motor comprises a circular rotor and a plurality of circumferentially spaced solenoids (32). The circular rotor comprises a plurality of circumferentially separated permanent magnets (31) and a plurality of spacers made of high magnetic permeability material. Each of the spacers is interposed between two of the permanent magnets (31) to reduce variations in axial magnetic flux. The plurality of circumferentially spaced solenoids (32) is provided each around a static solenoid housing. The solenoid housing is structured with a void portion through which the plurality of magnets (31) can pass when the rotor rotates around its axis. The motion of the magnets (31) with respect to the solenoids (32) is quasi-linear in the direction of a solenoid axis. Each of the plurality of solenoids (32) is energised with a timing sequence to ensure that it will interact with only one of the permanent magnets (31) at any given time, thereby minimizing back EMF.
Patent NZ-705402-A (NZ)
Title: Beverage container with improved puncture possibility
Inventor: SCHWARTZ ERHARD
IPC: B65D75/58
Filed: 2013-07-29
Abstract: Beverage container (1), in particular beverage pouch, which is provided with a piercing opening (2) for piercing with a drinking straw (5), in which beverage container (1) the piercing opening (2) is stamped and, on the inside, an outwardly exposed closure foil is fastened to the inner side around the piercing opening (2) by means of a welded joint (7), with the result that a sealed closure is produced, characterized in that a pocket (6) is formed between the inner welded edge (3) of the welded joint (7) and the lower edge (2b) of the piercing opening (2), in which pocket (6) the material of the beverage container (1) and the closure foil are not connected to one another.
Patent NZ-708414-A (NZ)
Title: Levodopa formulations for rapid relief of parkinson’s disease
Inventor: FREED MARTIN
IPC: A61K9/14
Filed: 2013-10-21
Abstract: The present invention provides methods of providing rapid relief of motor fluctuations in a Parkinson’s disease patient. The methods of the invention comprise pulmonary administration of levodopa by inhalation at therapeutically effective concentrations such that the patient’s plasma levodopa concentration increases by at least about 200 ng/ml within 10 minutes or less post inhalation as compared to the concentration of levodopa in the patient’s plasma prior to inhalation of the levodopa and wherein the patient’s plasma concentration remains increased by at least about 200 ng/ml for a time period of at least 15 minutes after inhalation. The methods of the invention are particularly useful for treatment of motor fluctuations which arise as a result of poorly controlled levodopa plasma levels in a patient.
Patent NZ-713251-A (NZ)
Title: An apparatus for dispensing a medicament.
Inventor: JOHN FOWLER
IPC: A61M5/31
Filed: 2014-08-13
Abstract: Disclosed is an apparatus for dispensing a medicament. The apparatus has: a housing having a first end and a second end and having a reservoir being arranged to hold a medicament; a rotatable means to enable a user to select a dose size of a medicament being a rotatable barrel and being adapted such that it has a safety means which prevents a medicament being expelled from the housing if the barrel is rotated in direction opposite to the direction which a user would rotate the barrel to select the dose size; a medicament expelling means; an activation member at the first end of the housing, the member adapted to be moved by a user between an initial position and an actuated position; and a removable disc member covering second end of the housing, the member being adapted to prevent medicament from dripping or leaking from it when the member is covering the end; the apparatus is formed such that when in use a user can select the dose size of a medicament using the rotatable means and when the activation member is moved to the actuated position it causes an audible sound and also causes the expelling means to expel the medicament from the second end of the housing.
Patent NZ-714649-A (NZ)
Title: Conduit for use in a respiratory apparatus
Inventor: HUBY RONALD JAMES
IPC: H05B3/56
Filed: 2007-11-08
Abstract: A conduit (4, 10) for use in a respiratory apparatus for delivering breathable gas to a patient, the conduit comprising: an inner tube (4a) defining a flow passage for the breathable gas; an outer tube (4f) surrounding the inner tube; and a spacing element (4b, 10b) provided between the inner tube and the outer tube. At least a portion of an outer surface of the outer tube comprises a coating.
Patent NZ-716700-A (NZ)
Title: A medical humidifier
Inventor: HUBY RONALD JAMES
IPC: A61M16/16
Filed: 2014-09-11
Abstract: A method of determining suitability of a humidifier wick of a humidifier for increasing an absolute humidity of a flow of air to be delivered to a patient’s airways by a respiratory therapy device, the humidifier comprising an air inlet configured to receive the flow of air from a pressure device, an air outlet configured to deliver the flow of air to a patient interface from the humidifier chamber with added humidity, the humidifier wick, and a controller configured to receive one more signals and/or generate one or more signals, and the humidifier wick being configured to retain a volume of water. The method comprises: providing a set of input values to the controller, the set of input values being indicative of a condition of the humidifier wick and the set of input values are provided to the controller by at least one of user input, at least one sensor, and a memory device; determining, based on the set of input values and a set of reference values, a condition set of the humidifier wick with the controller; and generating a signal with the controller based on the determined condition set to indicate a suitability of the humidifier wick for use in the humidifier.